Reduced NO synthesis and eNOS mRNA expression in endothelial cells from newborns with a strong family history of type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 7, 2007, Pages 559-566

  Alvarado Vásquez, Noé ^a   Zapata, Estrella ^b   Alcázer Leyva, Susana ^c   Massó, Felipe ^b   Montaño, Luis F ^d  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b Insituto Nacional de Cardiología Ignacio Chávez   (Mexico)

^c Instituto de Investigaciones Científicas Hans Selye A C   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Endothelium; Glucose; Nitric oxide; Nitric oxide synthase; Reaction oxygen species; Type 2 diabetes mellitus

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLUCOSE TRANSPORTER 1; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN P53;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FAMILY HISTORY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

ADULT; CELL DIVISION; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HUMANS; INFANT, NEWBORN; MEDICAL HISTORY TAKING; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; UMBILICAL VEINS;

EID: 35548936491     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.743     Document Type: Article

References (43)

1. Thamer C, Stumvoll M, Niess A, et al. Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes. Diabetes Care 2003; 26: 2126-2132.
2. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999; 48: 1856-1862.
3. Goldfine AB, Beckman JA, Betensky RA, et al. Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol 2006; 47: 2456-2461.
4. Reynolds SS, Yanek LR, Vaidya D, et al. Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease. Diabetes Res Clin Pract 2006; 74: 267-273.
5. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 2005; 511: 53-64.
6. Piatti PM, Monti LD, Zavaroni I, et al. Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes. J Clin Endocrinol Metab 2000; 85: 2416-2420.
7. Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 2002; 25: 560-564.
8. Sank A, Wei D, Reid J, et al. Human endothelial cells are defective in diabetic vascular disease. J Surg Res 1994; 57: 647-653.
9. Cester N, Rabini RA, Salvolini E, et al. Activation of endothelial cells during insulin-dependent diabetes mellitus: a biochemical and morphological study. Eur J Clin Invest 1996; 26: 569-573.
10. Park JL, Heilig CW, Brosius FC III. GLUT1-deficient mice exhibit impaired endothelium-dependent vascular relaxation. Eur J Pharmacol 2004; 496: 213-214.
11. Cappelli-Bigazzi M, Battaglia C, Pannain S, Chiariello M, Ambrosio G. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels. J Mol Cell Cardiol 1997; 29: 871-879.
12. Rosso A, Balsamo A, Gambino R, et al. p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J Biol Chem 2006; 281: 4339-4347.
13. Amore A, Cirina P, Conti G, et al. Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol Dial Transplant 2004; 19: 53-60.
14. Matoba S, Kang JG, Patino WD, et al. p53 regulates mitochondrial respiration. Science 2006; 312: 1650-1653.
15. Alvarado-Vasquez N, Paez A, Zapata E, et al. HUVECs from newborns with a strong family history of diabetes show diminished ROS synthesis in the presence of high glucose concentrations. Diabetes Metab Res Rev 2007; 23: 71-80.
16. Di Stefano R, Santoni T, Barsotti MC, et al. Different growth conditions for peripheral blood endothelial progenitors. Cardiovasc Radiat Med 2002; 3:172-175.
17. Huang YS, Huang WL, Lin WF, Chen MC, Jeng SR. An endothelial-cell-enriched primary culture system to study vascular endothelial growth factor (VEGF A) expression in a teleost, the Japanese eel (Anguilla japonica). Comp Biochem Physiol A Mol Integr Physiol 2006; 145: 33-46.
18. Foultier MT, Vonarx-Coinsmann V, Patrice T, Cloarec D, Xu XN, Combre A. Effects of high glucose concentration on survival and respiration of human endothelial cells. Biochimie 1992; 74: 975-979.
19. Sheng JZ, Wang D, Braun AP. DAF-FM [4-amino-5-methylamino-2′,7′-difluorofluorescein] diacetate detects impairment of agonist-stimulated nitric oxide synthesis by elevated glucose in human vascular endothelial cells: reversal by vitamin C and L-sepiapterin. J Pharmacol Exp Ther 2005; 315: 931-940.
20. Ferreiro CR, Chagas ACP, Carvalho MHC, et al. Expresión of Inducible Nitric Oxide Synthase is Increased in Patients with Heart Failure due to Ischemic Disease. Braz J Med Biol Res 2004; 37: 1313-1320.
21. Kim WS, Kim YY, Jang SJ, Kimm K, Jung MH. Glucose Transporter 1 [GLUT1] Expression is Associated with Intestinal Type of Gastric Carcinoma. J Korean Med Sci 2000; 15:420-424.
22. Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjectswith type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780-1784.
23. Ho FM, Liu SH, Liau CS, Huang PJ, Shiah SG, Lin-Shiau SY. Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage. J Cell Biochem 1999; 75: 258-263.
24. Ho FM, Lin WW, Chen BC, et al. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 2006; 18: 391-399.
25. Srinivasan S, Hatley ME, Bolick DT, et al. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004; 47: 1727-1734.
26. Lin LY, Lin CY, Ho FM, Liau CS. Up-regulation of the association between heat shock protein 90 and endothelial nitric oxide synthase prevents high glucose-induced apoptosis in human endothelial cells. J Cell Biochem 2005; 94: 194-201.
27. Sorrenti V, Mazza F, Campisi A, Vanella L, Li Volti G, Di Giacomo C. High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells. Curr Neurovasc Res 2006; 3: 49-54.
28. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ Res 1993; 73: 217-222.
29. DeSouza CA, Van Guilder GP, Greiner JJ, Smith DT, Hoetzer GL, Stauffer BL. Basal endothelial nitric oxide release is preserved in overweight and obese adults. Obes Res 2005; 13: 1303-1306.
30. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardialNO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 2007; 42: 271-279.
31. Sasso FC, Torella D, Carbonara O, et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol 2005; 46: 827-834.
32. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Baylis C. Peroxynitrite versus nitric oxide in early diabetes. Am J Hypertens 2003; 16: 761-766.
33. Hirsch C, Haller C. Effect of extracellular hypertonicity and alkalosis on endothelial-derived EA.hy 926 cells in vitro. Eur J Med Res 2004; 9: 71-77.
34. Malek AM, Goss GG, Jiang L, Izumo S, Alper SL. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke 1998; 29: 2631-2640.
35. Mandal AK, Ping T, Caldwell SJ, Bagnell R, Hiebert LM. Electron microscopic analysis of glucose-induced endothelial damage in primary culture: possible mechanism and prevention. Histol Histopathol 2006; 21: 941-950.
36. Mann GE, Yudlevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 2003; 83: 183-252.
37. Miele C, Formisano P, Condorelli G, et al. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 1997; 40: 421-429.
38. Pontiroli AE, Capra F, Veglia F, et al. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 [non-insulin-dependent] diabetes mellitus in different populations. Acta Diabetol 1996; 33: 193-197.
39. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64: 2627-2633.
40. Loeken MR. Advances in understanding the molecular causes of diabetes-induced birth defects. J Soc Gynecol Investig 2006; 13: 2-10.
41. Hayashi M, Sakata M, Takeda T, et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells. J Endocrinol 2004; 183: 145-154.
42. Patti ME. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology? Curr Opin Clin Nutr Metab Care 2004; 7: 383-390.
43. Patti ME. Gene expression in the pathophysiology of type 2 diabetes mellitus. Curr Diab Rep 2004; 4: 176-181.